Related Experiment Video
Updated: Jun 24, 2026

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
Interleukin-4 gene promoter polymorphism [C590T] and asthma in Kuwaiti Arabs
1Paediatrics Department, Faculty of Medicine, Kuwait University, Safat, Kuwait.
Background:
Recent studies have demonstrated an association of the T allele of a promoter polymorphism [C590T] of interleukin-4 (IL-4) gene with asthma/atopy in the US and Japanese populations, but data from the UK and Australian families failed to find an association. We have investigated the association of this [C590T] promoter polymorphism in Kuwaiti Arabs with asthma.
Methods:
This study included 184 subjects (84 asthmatics and 100 non-asthmatics, 47 of whom were totally unrelated normal healthy controls with no history of asthma/atopy in three generations of near relatives). The [C590T] promoter polymorphism of the IL-4 gene was analyzed by a polymerase chain reaction-restriction fragment length polymorphism method using the restriction enzyme AvaII.
Results:
The frequency of the T allele was found to be 0.79 in asthmatics, 0.75 in non-asthmatic first-degree relatives and 0.76 in unrealted controls in Kuwaiti Arabs. No significant difference was detected in the distribution of the three genotypes (TT, CT and CC) between the asthmatic, non-asthmatic relatives and the unrelated controls. The incidence of co-existing phenotypes e.g. hay fever, eczema and a positive skin prick test was significantly higher in asthmatics than in the non-asthmatics irrespective of the [C590T] genotype. However, within the asthmatic group, a higher incidence of eczema was detected in asthmatics with a heterozygous CT genotype compared to the asthmatics with a TT genotype.
Conclusions:
Our results do not show an association between [C590T] promoter polymorphism of the IL-4 gene and asthma in Kuwaiti Arabs. Our results are in keeping with the reports from the UK and Australian families (no association) but in contrast to the findings from US and Japanese populations (an association reported).
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Asthma I: Introduction

